151 related articles for article (PubMed ID: 37261705)
1. Radiation-induced angiosarcoma of the breast: individual participant meta-analysis of Japanese population.
Takehara Y; Matsuda N; Kobayashi D; Yoshida A; Takei J; Kanomata N; Tsunoda H; Yamauchi H; Hayashi N
Breast Cancer; 2023 Sep; 30(5):739-747. PubMed ID: 37261705
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy in early breast cancer.
Ejlertsen B
Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
[TBL] [Abstract][Full Text] [Related]
3. Angiosarcoma of the breast.
Vorburger SA; Xing Y; Hunt KK; Lakin GE; Benjamin RS; Feig BW; Pisters PW; Ballo MT; Chen L; Trent J; Burgess M; Patel S; Pollock RE; Cormier JN
Cancer; 2005 Dec; 104(12):2682-8. PubMed ID: 16288486
[TBL] [Abstract][Full Text] [Related]
4. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
5. Only grading has independent impact on breast cancer survival after adjustment for pathological response to preoperative chemotherapy.
Schneeweiss A; Katretchko J; Sinn HP; Unnebrink K; Rudlowski C; Geberth M; Beldermann F; Bastert G; Strittmatter HJ
Anticancer Drugs; 2004 Feb; 15(2):127-35. PubMed ID: 15075668
[TBL] [Abstract][Full Text] [Related]
6. Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer.
Chen W; Tu Q; Shen Y; Tang K; Hong M; Shen Y
World J Surg Oncol; 2021 Feb; 19(1):52. PubMed ID: 33602236
[TBL] [Abstract][Full Text] [Related]
7. Impact of Body Mass Index on Presence of ctDNA and Disease Recurrence after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: Analysis from BRE12-158.
Ballinger TJ; Jiang G; Kassem N; Radovich M; Schneider BP
Clin Cancer Res; 2021 Feb; 27(4):1195-1199. PubMed ID: 33199491
[TBL] [Abstract][Full Text] [Related]
8. Taxane-based combinations as adjuvant chemotherapy for node-positive ER-positive breast cancer based on 2004-2009 data from the Breast Cancer Registry of the Japanese Breast Cancer Society.
Hojo T; Masuda N; Iwamoto T; Niikura N; Anan K; Aogi K; Ohnishi T; Yamauchi C; Yoshida M; Kinoshita T; Masuoka H; Sagara Y; Sakatani T; Kojima Y; Tsuda H; Kumamaru H; Miyata H; Nakamura S
Breast Cancer; 2020 Jan; 27(1):85-91. PubMed ID: 31327134
[TBL] [Abstract][Full Text] [Related]
9. Survival Analysis After Neoadjuvant Chemotherapy With Trastuzumab or Lapatinib in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the GeparQuinto (G5) Study (GBG 44).
Untch M; von Minckwitz G; Gerber B; Schem C; Rezai M; Fasching PA; Tesch H; Eggemann H; Hanusch C; Huober J; Solbach C; Jackisch C; Kunz G; Blohmer JU; Hauschild M; Fehm T; Nekljudova V; Loibl S;
J Clin Oncol; 2018 May; 36(13):1308-1316. PubMed ID: 29543566
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of residual node involvement in operable breast cancer after induction chemotherapy.
Curé H; Amat S; Penault-Llorca F; le Bouëdec G; Ferrière JP; Mouret-Reynier MA; Kwiatkowski F; Feillel V; Dauplat J; Chollet P
Breast Cancer Res Treat; 2002 Nov; 76(1):37-45. PubMed ID: 12408374
[TBL] [Abstract][Full Text] [Related]
11. [Impact of adjuvant chemotherapy on the prognosis of hormone receptor negative breast cancer with residual lymph node disease after neoadjuvant chemotherapy].
Wang X; He YJ; Li JF; Xie YT; Wang TF; Fan ZQ; Ouyang T
Zhonghua Yi Xue Za Zhi; 2017 May; 97(20):1576-1579. PubMed ID: 28592065
[No Abstract] [Full Text] [Related]
12. Cutaneous Radiation-associated Breast Angiosarcoma: Radicality of Surgery Impacts Survival.
Li GZ; Fairweather M; Wang J; Orgill DP; Bertagnolli MM; Raut CP
Ann Surg; 2017 Apr; 265(4):814-820. PubMed ID: 28267696
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
[TBL] [Abstract][Full Text] [Related]
14. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.
Fisher B; Bryant J; Wolmark N; Mamounas E; Brown A; Fisher ER; Wickerham DL; Begovic M; DeCillis A; Robidoux A; Margolese RG; Cruz AB; Hoehn JL; Lees AW; Dimitrov NV; Bear HD
J Clin Oncol; 1998 Aug; 16(8):2672-85. PubMed ID: 9704717
[TBL] [Abstract][Full Text] [Related]
15. Is there a role for adjuvant therapy in radiation-induced angiosarcoma of the breast? A case report and review of the literature.
Caterino M; De Felice M; Poliero L; Mazzarella G; Pirozzi M; Facchini S; Ciardiello F; Fasano M
Eur Rev Med Pharmacol Sci; 2023 May; 27(9):4169-4174. PubMed ID: 37203843
[TBL] [Abstract][Full Text] [Related]
16. Primary and secondary breast angiosarcoma: single center report and a meta-analysis.
Abdou Y; Elkhanany A; Attwood K; Ji W; Takabe K; Opyrchal M
Breast Cancer Res Treat; 2019 Dec; 178(3):523-533. PubMed ID: 31522347
[TBL] [Abstract][Full Text] [Related]
17. The role of postmastectomy radiation therapy after neoadjuvant chemotherapy in clinical stage II-III breast cancer patients with pN0: a multicenter, retrospective study (KROG 12-05).
Shim SJ; Park W; Huh SJ; Choi DH; Shin KH; Lee NK; Suh CO; Keum KC; Kim YB; Ahn SD; Kim SS; Ha SW; Chie EK; Kim K; Shin HS; Kim JH; Lee HS
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):65-72. PubMed ID: 24161425
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy analysis of THP-containing regimens as neoadjuvant and adjuvant chemotherapy for primary breast cancer].
Wang LZ; Ouyang T; Wang TF; Xie YT; Fan ZQ; Fan T; Lin BY; Li JF
Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):143-6. PubMed ID: 22780935
[TBL] [Abstract][Full Text] [Related]
19. Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18.
Fisher ER; Wang J; Bryant J; Fisher B; Mamounas E; Wolmark N
Cancer; 2002 Aug; 95(4):681-95. PubMed ID: 12209710
[TBL] [Abstract][Full Text] [Related]
20. Extent of resection and role of adjuvant treatment in resected localized breast angiosarcoma.
McClelland S; Hatfield J; Degnin C; Chen Y; Mitin T
Breast Cancer Res Treat; 2019 Jun; 175(2):409-418. PubMed ID: 30820717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
